Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Aug 17, 2025

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on: October 18, 2024

770

Methylene Blue in Refractory Shock.

Som N Chalise1, Taaliba A Sahib1, Gregory A Boyer2

  • 1Pulmonary and Critical Care Medicine, Riverside Health System, Newport News, USA.

Cureus
|December 12, 2022
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Yield of Malignant Pleural Effusion in Various Primary and Metastatic Cancers: Insights Across Cancer Subtypes.

Pulmonary medicine·2026
Same author

Amiodarone-Induced Pulmonary Toxicity Presenting as Unilateral Fibrosis: A Case Report.

Cureus·2026
Same author

Physicochemical, Nutritional, and Structural Characterization of a Novel Meat-Based Hummus.

Foods (Basel, Switzerland)·2025
Same author

Thirty-Nine Years Later: A Case Report and Literature Review of Delayed Pleural and Pericardial Effusions After Chest Radiotherapy for Non-Hodgkin Lymphoma.

Cureus·2025
Same author

Commentary on "Development of postgraduate training in critical care medicine for nurse practitioners and physician assistants" JAANP, 33(12):1116-1119, December 2021.

Journal of the American Association of Nurse Practitioners·2023
Same author

Effects of Concurrent Dosing on the Efficacy of Tissue Plasminogen Activator and Deoxyribonuclease in the Treatment of Pleural Infection.

Cureus·2023
Same journal

Immunohistochemistry (IHC) Versus Genomic Profiling in Cancer: Roles in Precision Medicine.

Cureus·2026
Same journal

Pediatric Nasal Tip Reconstruction After a Donkey Bite Using an Expanded Paramedian Forehead Flap With Conchal Cartilage Grafts: A Case Report.

Cureus·2026
Same journal

Splenic Rupture: A Delayed and Rare Complication of Colonoscopy.

Cureus·2026
Same journal

Super-refractory Status Epilepticus in Febrile Infection-Related Epilepsy Syndrome Triggered by Influenza A: A Pediatric Case Report.

Cureus·2026
Same journal

Comparative Evaluation of Serum Peroxiredoxin 2 (PRDX2), Serum Peroxiredoxin 4 (PRDX4), and Plasma Methylated Septin 9 (mSEPT9) Levels Against Conventional Biomarkers for Early Detection of Colorectal Cancer: A Study Protocol.

Cureus·2026
Same journal

Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disease: A Narrative Review.

Cureus·2026
See all related articles

Refractory shock in intensive care units (ICU) poses a high mortality risk. Methylene blue offers a potential treatment option for patients unresponsive to standard vasopressor therapy, as suggested by this case report and literature review.

Area of Science:

  • Critical Care Medicine
  • Pharmacology

Background:

  • Shock is a common and life-threatening condition in intensive care units (ICUs).
  • Standard treatment involves vasopressors and addressing the underlying cause, but some patients remain refractory.
  • Refractory shock carries a significant risk of mortality.

Observation:

  • This case report focuses on a patient experiencing refractory shock.
  • The patient did not respond adequately to conventional vasopressor treatments.
  • Methylene blue was considered as an alternative therapeutic strategy.

Findings:

  • Methylene blue has a history of use in managing refractory shock with reported success.
  • The case report details the administration and observed effects of methylene blue in a specific patient scenario.
Keywords:
methylene blue infusionnitric oxide-cgmp pathwayoverdoserefractory shockvasoplegia

More Related Videos

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
12:19

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke

Published on: March 11, 2018

11.5K
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
06:39

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse

Published on: September 12, 2018

27.0K

Related Experiment Videos

Last Updated: Aug 17, 2025

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on: October 18, 2024

770
An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke
12:19

An In Vivo Assessment of Blood-Brain Barrier Disruption in a Rat Model of Ischemic Stroke

Published on: March 11, 2018

11.5K
An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse
06:39

An Optimized Evans Blue Protocol to Assess Vascular Leak in the Mouse

Published on: September 12, 2018

27.0K
  • A literature review provides context on previous applications and outcomes of methylene blue for shock.

    • Implications:

    • Methylene blue may represent a viable therapeutic option for select ICU patients with refractory shock.
    • Further research is warranted to establish the efficacy and safety of methylene blue in this patient population.
    • This case contributes to the understanding of adjunctive therapies for severe hemodynamic instability.